Delayed immune-mediated adverse effects related to polyacrylamide dermal fillers: Clinical findings, management, and follow-up

Dermatologic Surgery

Volumn 35, Issue SUPPL. 1, 2009, Pages 360-366

  Alijotas Reig, Jaume ^a,b,e   Garcia Gimenez, Victor ^c,d   Miró Mur, Francesc ^a   Vilardell Tarrés, Miquel ^a,b  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c Europa Medical Centre   (Spain)

^d SEMFYC International Section   (Spain)

^e NONE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOPURINOL; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; BETAMETHASONE; C REACTIVE PROTEIN; CIPROFLOXACIN; COMPLEMENT; FIBRINOGEN; HYDROXYCHLOROQUINE; IBUPROFEN; NONSTEROID ANTIINFLAMMATORY AGENT; POLYACRYLAMIDE; PREDNISONE;

ABSCESS; ADULT; ARTICLE; BIOPSY; BLOOD EXAMINATION; CLINICAL ARTICLE; CYST; FACE EDEMA; FEMALE; FOLLOW UP; GRANULOMA; HUMAN; HYPERGAMMAGLOBULINEMIA; INFLAMMATORY NODULE; INJECTION; PRIORITY JOURNAL; REMISSION; SKIN INDURATION; SKIN NODULE; SYMPTOM;

ACRYLIC RESINS; ADULT; ANTI-INFLAMMATORY AGENTS; CLINICAL PROTOCOLS; COSMETIC TECHNIQUES; FACE; FEMALE; GRANULOMA; HUMANS; HYDROGELS; MIDDLE AGED; PROSPECTIVE STUDIES; PROSTHESES AND IMPLANTS; TIME FACTORS;

EID: 59349086964     PISSN: 10760512     EISSN: 15244725     Source Type: Journal    
DOI: 10.1111/j.1524-4725.2008.01041.x     Document Type: Article

References (36)

1. De Boulle K. Management of complications after implantation of fillers. J Cosmet Dermatol 2004 3 : 2 15.
2. Ellis DA, Makdessian AS, Brown DJ. Survey of future injectables. Facial Plast Surg Clin North Am 2001 9 : 405 11.
3. Frank PJ. Cosmetic symposium: Restylane. The Dermatologic Society of Greater New York. Available at : Accessed February 2, 2005.
4. Engelman DE, Bradley B, Glodberg DJ. Dermal fillers: complications and informed consent. J Cosmet Laser Ther 2005 7 : 29 32.
5. Andre P, Lowe NJ, Parc A, et al. Adverse reactions to dermal fillers: a review of European experiences. J Cosmet Laser Ther 2005 7 : 171 6.
6. Duffy DM. Complications of fillers: overview. Dermatol Surg 2005 31 : 1626 33.
7. Bergeret-Galley C. Comparison of resorbable soft-tissue fillers. Aesth Surg J 2004 24 : 33 46.
8. Christensen L, Breiting V, Janssen M, et al. Adverse reactions to injectable soft tissue permanent fillers. Aesth Plast Surg 2005 29 : 34 48.
9. Breiting V, Aasred A, Jorgensen A, et al. A study on patients treated with polyacrylamide hydrogel injection for facial corrections. Aesth Plast Surg 2004 28 : 45 53.
10. Christensen LC, Breiting V, Aasred A, et al. Long-term effects of polyacrylamide hydrogel in human breast tissue. Plast Reconst Surg 2003 111 : 1883 90.
11. Zarini E, Supino R, Pratesi G, et al. Biocompatibility and tissue interactions of a new filler material for medical use. Plast Reconst Surg 2004 114 : 934 42.
12. Von Buelow S, Pallua N. Efficacy and safety of polyacrylamide hydrogel for facial soft-tissue augmentation in a 2-year follow-up: a prospective multicenter study for evaluation of safety and aesthetic results in 101 patients. Plast Reconst Surg 2006 118 (3 Suppl) : 85S 91S.
13. Border KW, Cohen SR. An overview of permanent and semipermanent fillers. Plast Reconst Surg 2006 118 (3 Suppl) : 7S 13S.
14. Qiao Q, Wang X, Sun J, et al. Management for postoperative complications of breast augmentation by injected polyacrylaide hydrogel. Aesth Plast Surg 2005 29 : 156 61.
15. Amin SP, Marmur ES, Goldberg DJ. Complications from injectable polyacrylamide gel, a new nonbiodegradable soft tissue filler. Dermatol Surg 2004 30 : 1507 9.
16. Christensen LH, Breiting VB, Vuust J, et al. Adverse reactions following injection with permanent facial filler, polyacrylamide hydrogel (Aquamid): causes and treatment. Eur J Plast Surg 2006 28 : 464 71.
17. Alijotas-Reig J, Garcia-Gimenez V. Delayed immune-mediated adverse effects related to hyaluronic acid and acrylic hydrogel dermal fillers: clinical findings, long term follow-up and review of the literature. J Eur Acad Dermatol Venereol 2008 22 : 150 61.
18. Pons-Guiraud A. Actualisation des effets secundaires des produits de comblements des rides. Now Dermatol 2003 22 : 205 10.
19. Cheng N, Wang Y, Wang J, et al. Complications of breast augmentation with injected hydrophilic polyacrylamide gel. Aesth Plast Surg 2002 26 : 375 82.
20. James DG, Williams WJ. Sarcoidosis and other granulomatous disorders. In : Smith LLH, editor. Major Problems in Internal Medicine. Philadelphia : W.B. Saunders Co 1985 24, p. 1 254.
21. Antonovic D, Callen J. Development of sarcoidosis in cosmetic tattoos. Arch Dermatol 2005 141 : 869 72.
22. Dal Sacco D, Cozzani E, Parodi A, Rebora A. Scar sarcoidosis alter hyaluronic acid injection. Int J Dermatol 2005 44 : 411.
23. Lemperle G, Morhenn V, Charrier U. Human histology and persistence of various injectable filler substances for tissue augmentation. Aesth Plast Surg 2003 27 : 354 66.
24. Passy S. Implantes de polimetacrilato. Un nuevo método para corregir defectos corporales sin cirugía. Int J Cosmetic Med Surg (ed. esp) 2002 4 : 23 7.
25. Lemperle G, Kind P. Biocompatibility of Artecoll. Plast Reconstr Surg 1999 103 : 338 40.
26. Filion MC, Phillips NC. Pro-inflammatory activity of containing DNA in hyaluronic acid preparations. J Pharm Pharmacol 2001 53 : 556 61.
27. Arbuckle MR, McClain MT, Rubertone MV, et al. Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med 2003 349 : 1526 33.
28. Rynes RI. Antimalarial drugs. In : Kelley WN, Harris ED, Ruddyn S, Sledge CB, editors. Textbook of Rheumatology. 4th edition. Philapelphia : W.B. Saunders 1993. p. 731 42.
29. Alijotas-Reig J, Garcia-Gimenez V, Miró-Mur F, Vilardell-Tarrés M. Delayed immune-mediated adverse effects of polyalkylimide dermal fillers: clinical findings and long-term follow-up. Arch Dermatol 2008 144 : 637 42.
30. Wozniacka A, Lesiak A, Narbutt J, et al. Chloroquine treatment influences proinflammatory cytokine level in systemic lupus erythematosus patients. Lupus 2006 15 : 268 75.
31. Reisemberger EM, Landthaler M, Wiest I, et al. Foreign body granulomas caused by polymethtylmethacrylate microspheres: succesful tratment with allopurinol. Arch Dermatol 2003 139 : 17 20.
32. Brechtel B, Haass N, Henz BM, Kolde G. Allopurinol: a therapeutic alternative for disseminated cutaneous sarcoidosis. Br J Dermatol 1996 135 : 307 9.
33. Christen U, von Herrath G. Infections and autoimmunity. Good or bad? J Immunol 2005 174 : 7481 86.
34. a Edición. Madrid : Elsevier España, S.A. 2007.
35. Senet P, Bachelez H, Ollivaud L, et al. Minocicline for the treatment of cutaneous silicone granulomas. Br J Dermatol 1999 140 : 985 7.
36. Bachelez H, Senet P, Cadranel J, et al. The use of tretraciclines for the treatment of sarcoidosis. Arch Dermatol 2001 137 : 69 73.